Skip to main content

Jessica Hagen

By Jessica Hagen | 04:06 pm | December 28, 2023
The U.S. Court of Appeals for the Federal Circuit has temporarily stopped an import ban issued by the International Trade Commission prohibiting the sale of Apple Watch Series 9 and Watch Ultra 2 in the U.S.
By Jessica Hagen | 02:01 pm | December 28, 2023
The company offers diagnostic tests and therapeutics to detect and treat endometriosis, female fertility and bacterial vaginosis.
By Jessica Hagen | 05:24 pm | December 27, 2023
From the end of the Public Health Emergency to the launch of ChatGPT and the Apple Vision Pro, executives reflect on what stood out to them this year.
By Jessica Hagen | 01:57 pm | December 27, 2023
President Biden failed to overturn a U.S. International Trade Commission ban on sales and imports of Watch Series 9 and Watch Ultra 2.
By Jessica Hagen | 10:39 pm | December 26, 2023
Employers aligned with Carrum can offer two years of treatment coverage to non-metastatic breast cancer patients via Florida Cancer Specialists & Research Institute.
By Jessica Hagen | 01:41 pm | December 26, 2023
Jay Rughani, investment partner at a16z, discusses 2023 events, predictions for digital health funding in 2024 and proper AI regulation to avoid stifling innovation.
By Jessica Hagen | 02:12 pm | December 21, 2023
Guidehealth acquired Arcadia's managed services organization and value-based care services division. It also signed an agreement to leverage its data analytics platform.
By Jessica Hagen | 03:47 pm | December 20, 2023
The award will support veterans' access to the California-based virtual reality company's FDA-authorized at-home chronic low back pain offering, RelieVRx.
By Jessica Hagen | 12:54 pm | December 20, 2023
The company announced the appointments of numerous individuals to its executive team and will use the funds to expand its partnerships and oncology platform.
By Jessica Hagen | 03:26 pm | December 19, 2023
The company will use the funds to prepare for commercialization in the U.S., enhance its platform and seek FDA clearance for its VERAFEYE platform.